For instance, the lead pQTL for SARM1, which had an effect on amyotrophic lateral sclerosis risk in the initial analysis (p = 1.76 × 10−08), did not provide evidence of an effect with any of the 700 outcomes assessed based on multiple testing corrections (Figure 3B). Here, SARM1 is linked to amyotrophic lateral sclerosis.